BluTech lenses make for some high-tech specs


Share with others:


Print Email Read Later

Google Glass has been hogging the spotlight when it comes to eyewear, but get ready to see new technology designed for those with old-fashioned prescription eyeglasses.

About 64 percent of Americans wear glasses to improve vision. Many can't stand them, complaining that glasses are cumbersome, headache-inducing or don't work in all situations. Meanwhile, the growing amount of time people spend in front of computers and mobile devices has also raised concern about the potential damaging effects on eyesight.

That's spurring innovation among eye specialists, who say the glasses industry has been largely stagnant since bifocals were invented by Benjamin Franklin in the 18th century.

"It's a marketplace with slow technology adoption. There hasn't been new technology in eyeglasses in forever," said Stephen Kurtin, chairman of Superfocus, which makes adjustable-focus glasses that enable wearers to choose the best focus for every distance. The glasses are intended for people afflicted by presbyopia, an aging condition that affects the eye's ability to focus on close objects, and are made by a handful of companies, including Superfocus of Van Nuys, Calif., and Britain's Adlens.

Now companies are designing a host of solutions to aid glasses wearers, including futuristic lenses and even an iPhone application that developers say can help people wean themselves off glasses.

One area of focus has been on reducing eyestrain for people who spend several hours a day staring at computers, tablets and smartphones. Many optometrists believe the light emitted from such devices could damage a viewer's eyesight over time, although that hasn't been proven.

Still, lens companies are rolling out a slew of new lenses that they say will help ward off those potentially harmful effects.

"Why would you take the risk? Let the science unfold and let us protect ourselves as it's unfolding," said Don Oakley, president of VSP Optics Group, which this year introduced its Unity with BluTech lenses.

BluTech lenses are infused with melanin, a natural pigment found in the iris of the eye, to help filter out high-energy blue light and UVA/UVB radiation while allowing what Mr. Oakley called "innocuous" light to pass through.

The melanin gives BluTech lenses a yellowish hue, and is available for any prescription. Other companies produce lenses with blue-light filtering coatings.

Mr. Oakley said BluTech lenses reduce eyestrain and fatigue from long hours spent in front of the computer. Adding BluTech lenses to a pair of glasses is typically less than $100; they can be worn indoors and outdoors and can also be added to nonprescription glasses.

He cautioned that BluTech "doesn't prevent anything per se but it protects."

Although many eye doctors think all that time staring at your smartphone is bad for your eyes, one firm is encouraging people to use mobile devices to improve their vision.

GlassesOff Inc. is gearing up to launch an iPhone app this year that it claims can enhance near-vision sharpness. The New York company contends that human vision is based on two main factors: the quality of an image captured by the eyes and the image-processing capabilities of the brain as it interprets the image.

By spending 12 to 15 minutes a day, three times a week for three months completing a gamelike program, GlassesOff says, a user can improve the image-processing function by teaching the brain to better interpret blurred images.

The app is tailored for each individual and adapts according to his or her progress; the goal is to wean a viewer off reading glasses altogether.

The notion that people can improve their eyesight through eye exercises has drawn skepticism from some optometrists and ophthalmologists.

But in a paper published in the journal Scientific Reports, the scientists behind GlassesOff said participants in a study at the University of California-Berkeley showed a nearly 10-year improvement in eye age.

businessnews

First Published October 12, 2013 8:00 PM


Advertisement
Advertisement
Advertisement

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here